Synbias Pharma/GeminiPharmChem

CDMO · Switzerland

Our primary specialization lies in the development of synthesis routes and manufacturing of highly potent Active Pharmaceutical Ingredients (APIs), primarily used in cancer therapies Source (opens in a new tab)

Website: https://geminipharmchem.com/
Headquarters: CH
Provider types: CDMO, API manufacturer